In Brief: OTC vaginal contraceptives
This article was originally published in The Tan Sheet
Executive Summary
OTC vaginal contraceptives: FDA's administrative record reopened until March 3, 1997 "to allow for comment on matters considered at the Nov. 22 joint meeting of the Nonprescription Drugs, Reproductive Health Drugs, Anti-Infective Drugs and Antiviral Drugs Advisory Committees," the agency announces in the Dec. 19 Federal Register. The committees discussed issues relevant to FDA's regulation of OTC spermicides, including the kind and scope of efficacy studies needed for the products ("The Tan Sheet" Nov. 25, pp. 1-7)...